JACOBIO-B (01167) Appoints Wang Yi as Co-Chief Executive Officer

Stock News

Yesterday

JACOBIO-B (01167) announced that to further advance the group's global strategic layout and enhance cross-regional operational efficiency, the board of directors has approved the establishment of a "Co-Chief Executive Officer" (Co-CEO) system. Dr. Andrea Wang-Gillam (Wang Yi), currently serving as Chief Medical Officer (CMO), was appointed as the company's Co-CEO on November 12, 2025.

Dr. Wang Yi has extensive experience in the international pharmaceutical market, with deep expertise in clinical trial regulations, regulatory environments, healthcare systems, and commercialization logic in Europe and the U.S. With over 20 years of experience as an oncologist in the U.S., she has led multiple clinical trials for anti-cancer drugs and is internationally recognized as a clinical expert in gastrointestinal oncology. Additionally, as an associate professor at Washington University in St. Louis, she has long been engaged in foundational oncology research, demonstrating profound insights into global clinical strategies and research directions for anti-cancer drugs.

This adjustment represents a key step in the group's globalization strategy, aiming to establish a synergistic model of "global strategic coordination + regional execution" to create greater value for shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1100159944"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100159944\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100159944?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 06:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100159944","market":"sg","top_or_hot":-1,"title":"JACOBIO-B (01167) Appoints Wang Yi as Co-Chief Executive Officer","media":"Stock News","content":"<p>JACOBIO-B (01167) announced that to further advance the group's global strategic layout and enhance cross-regional operational efficiency, the board of directors has approved the establishment of a \"Co-Chief Executive Officer\" (Co-CEO) system. Dr. Andrea Wang-Gillam (Wang Yi), currently serving as Chief Medical Officer (CMO), was appointed as the company's Co-CEO on November 12, 2025.</p>\n<p>Dr. Wang Yi has extensive experience in the international pharmaceutical market, with deep expertise in clinical trial regulations, regulatory environments, healthcare systems, and commercialization logic in Europe and the U.S. With over 20 years of experience as an oncologist in the U.S., she has led multiple clinical trials for anti-cancer drugs and is internationally recognized as a clinical expert in gastrointestinal oncology. Additionally, as an associate professor at Washington University in St. Louis, she has long been engaged in foundational oncology research, demonstrating profound insights into global clinical strategies and research directions for anti-cancer drugs.</p>\n<p>This adjustment represents a key step in the group's globalization strategy, aiming to establish a synergistic model of \"global strategic coordination + regional execution\" to create greater value for shareholders.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JACOBIO-B (01167) Appoints Wang Yi as Co-Chief Executive Officer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJACOBIO-B (01167) Appoints Wang Yi as Co-Chief Executive Officer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-13 06:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JACOBIO-B (01167) announced that to further advance the group's global strategic layout and enhance cross-regional operational efficiency, the board of directors has approved the establishment of a \"Co-Chief Executive Officer\" (Co-CEO) system. Dr. Andrea Wang-Gillam (Wang Yi), currently serving as Chief Medical Officer (CMO), was appointed as the company's Co-CEO on November 12, 2025.</p>\n<p>Dr. Wang Yi has extensive experience in the international pharmaceutical market, with deep expertise in clinical trial regulations, regulatory environments, healthcare systems, and commercialization logic in Europe and the U.S. With over 20 years of experience as an oncologist in the U.S., she has led multiple clinical trials for anti-cancer drugs and is internationally recognized as a clinical expert in gastrointestinal oncology. Additionally, as an associate professor at Washington University in St. Louis, she has long been engaged in foundational oncology research, demonstrating profound insights into global clinical strategies and research directions for anti-cancer drugs.</p>\n<p>This adjustment represents a key step in the group's globalization strategy, aiming to establish a synergistic model of \"global strategic coordination + regional execution\" to create greater value for shareholders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1100159944","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100159944","pubTimestamp":1762987214,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"JACOBIO-B (01167) announced that to further advance the group's global strategic layout and enhance cross-regional operational efficiency, the board of directors has approved the establishment of a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","01167":"加科思-B","BK1574":"生物医药B类股"},"translate_title":"雅可比-B(01167)委任王毅为联席行政总裁","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01167":1},"content_text":"JACOBIO-B (01167) announced that to further advance the group's global strategic layout and enhance cross-regional operational efficiency, the board of directors has approved the establishment of a \"Co-Chief Executive Officer\" (Co-CEO) system. Dr. Andrea Wang-Gillam (Wang Yi), currently serving as Chief Medical Officer (CMO), was appointed as the company's Co-CEO on November 12, 2025.\nDr. Wang Yi has extensive experience in the international pharmaceutical market, with deep expertise in clinical trial regulations, regulatory environments, healthcare systems, and commercialization logic in Europe and the U.S. With over 20 years of experience as an oncologist in the U.S., she has led multiple clinical trials for anti-cancer drugs and is internationally recognized as a clinical expert in gastrointestinal oncology. Additionally, as an associate professor at Washington University in St. Louis, she has long been engaged in foundational oncology research, demonstrating profound insights into global clinical strategies and research directions for anti-cancer drugs.\nThis adjustment represents a key step in the group's globalization strategy, aiming to establish a synergistic model of \"global strategic coordination + regional execution\" to create greater value for shareholders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}